https://www.selleckchem.com/Bcl-2.html
However, currently no treatment is available to remove amyloid deposited in the tissue. Thus, early diagnosis is still critical to afford the best efficacy of available therapies.OBJECTIVE The aim of this study was to determine the incidence of newly detected atrial fibrillation (AF) in patients following dual-chamber pacemaker (PPM) implantation and to define the clinical predictors of new-onset AF in a Chinese cohort. METHODS A total of 219 patients without documented AF that underwent dual-chamber PPM implantation for sick sinus syndrome (SSS)
Like
Comment
Share
